Copyright
©The Author(s) 2015.
World J Hematol. Feb 6, 2015; 4(1): 1-9
Published online Feb 6, 2015. doi: 10.5315/wjh.v4.i1.1
Published online Feb 6, 2015. doi: 10.5315/wjh.v4.i1.1
Table 2 Phase 3 novel oral anticoagulant trials
| RECOVER and RECOVER II | EINSTEIN DVT | EINSTEIN PE | AMPLIFY | Hokusai VTE | |
| Drug | Dabigatran | Rivaroxaban | Rivaroxaban | Apixaban | Edoxaban |
| N | 5128 | 3449 | 4832 | 5395 | 8240 |
| Indication | VTE | DVT | PE | VTE | VTE |
| Heparin bridge | Yes | No | No | No | Yes |
| Duration (mo) | 6 | 3, 6, 12 | 3, 6, 12 | 6 | 3, 6, 12 |
- Citation: Jo HE, Barnes DJ. Role of novel oral anticoagulants in the management and prevention of venous thromboembolism. World J Hematol 2015; 4(1): 1-9
- URL: https://www.wjgnet.com/2218-6204/full/v4/i1/1.htm
- DOI: https://dx.doi.org/10.5315/wjh.v4.i1.1